MedTrace Logo

A Food-Drug Interaction Study of Serum Urate After Oral Inosine

NCT02614469 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 18

Last updated 2017-03-29

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to assess the effects of food on the amount of urate in the body after a single oral dose of inosine.

Conditions

  • Healthy

Interventions

DRUG

Inosine

Inosine, 1000 mg

Sponsors & Collaborators

  • Michael J. Fox Foundation for Parkinson's Research

    collaborator OTHER

  • The Parkinson Alliance

    collaborator OTHER

  • Michael Alan Schwarzschild

    lead OTHER

Principal Investigators

  • Mason Freeman, M.D. · Massachusetts General Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-03-31
Primary Completion
2016-04-30
Completion
2016-05-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02614469 on ClinicalTrials.gov